A birth cohort study of viral infections in Vietnamese infants and children: study design, methods and characteristics of the cohort
© Anders et al.; licensee BioMed Central Ltd. 2013
Received: 30 September 2013
Accepted: 3 October 2013
Published: 8 October 2013
In Ho Chi Minh City, Vietnam, more than one-third of admissions to the two paediatric hospitals are attributable to four infectious syndromes: dengue, diarrhoeal disease, acute respiratory infection, and hand, foot and mouth disease. We have established a large prospective birth cohort study to investigate individual, environmental, virological, and immunological determinants of infection and disease in infants. Specific research questions are focused on the role of maternal antibody in protection against infection in infancy, and the adaptive immune response to vaccination and natural infection. This paper presents the cohort design, methods, and baseline characteristics of the participants enrolled in the first two years.
Women are enrolled prior to delivery at one hospital in each of two catchment areas: an urban district in central HCMC, and a mixed urban/rural district in the Mekong Delta 150 km southwest of HCMC. Infants are enrolled within 3 days of birth, and maternal and cord blood samples are collected. Routine blood samples and data on growth, health status and vaccinations are collected from infants at scheduled visits at 4, 9 and 12 months. Clinical data and specimens are collected from infants presenting at a study clinic, or admitted to hospital, with any of the the four infectious syndromes of interest.
In four years since since the study began in July 2009, >6400 infants have been enrolled, and enrolment is ongoing. Attrition is low: 84% of participants have completed the full 12-month follow-up period. Baseline characteristics of the first 4300 enrollees are presented here. We have demonstrated the feasibility of establishing a large prospective study of infectious diseases in infancy in a resource-limited setting, with minimal loss to follow-up. Our linked socio-demographic, clinical and laboratory data will help elucidate the viral aetiology and epidemiology of common infectious diseases of infancy, and can inform the implemention of existing and future vaccines. This study furthermore provides a platform to which additional endpoints could be added in the future.
KeywordsCohort studies Epidemiology Infections diseases Viral infectious Infants
A number of large birth cohort studies have been established in south east Asia that focus on environmental exposures, child health and development, asthma, allergy and obesity in children, [1–3] however there are few published longitudinal studies of infection and immunity in infants and young children in this region [4–6]. Studies of infectious disease aetiology and epidemiology are often cross-sectional and hospital-based in design, which presents a number of limitations including a focus on more severe illness, a lack of information on pre-infection risk factors, an inability to estimate incidence due to the lack of an appropriate denominator, and an inability to identify asymptomatic infections which may be an important contributor to transmission at a population level. Although a wealth of literature from prospective community-based studies does exist for a large range of infectious diseases which addresses questions of case burden, aetiology, epidemiological risk factors, pathogenesis and immune response, many studies focus only on one pathogen or syndrome and do not therefore give a broad picture of the longitudinal infectious disease experience of participants. Others are limited by small sample size, lack of routine blood sampling for serological detection of asymptomatic infections, or lack of year-round case detection.
In southern Vietnam, more than one-third of admissions to the two referral paediatric hospitals in HCMC are attributable to 4 infectious diseases and syndromes: dengue, diarrhoeal disease, acute respiratory infection (ARI), and hand, foot and mouth disease (HFMD), with an average of 147,000 patients admitted with these syndromes annually to these two hospitals alone (personal communication: Corinne Thompson). The median age of dengue cases in southern Vietnam is 9 years, however hospital-based studies have demonstrated a second peak of hospitalisations for severe dengue among infants aged 4–10 months  and that young children <5 years are at higher risk of mortality from dengue than older children . Children under 2 years account for the majority of hospital admissions with diarrhoeal disease [9, 10] and ARI,  and the median age of children admitted to hospital in HCMC with HFMD was 20 months during a recent epidemic,  in which enterovirus 71 emerged as a major pathogen associated with severe disease.
We have established a prospective birth cohort spanning an urban and a semi-rural population in southern Vietnam, that serves as a platform for longitudinal epidemiological, clinical and immunological studies of these four major infectious syndromes in Vietnamese infants and children. The primary objective around which this study was designed was to determine the role of passively acquired maternal antibody in protection against and pathogenesis of dengue virus infection during the first year of life. The secondary objectives were to determine the incidence of acute respiratory infection and gastrointestinal infections in the first year of life, the viral aetiology of those infections, and the risk factors associated with viral infections during infancy.
Study population and location
Participant enrolment and collection of baseline data and samples
Women delivering at Hung Vuong obstetric hospital in HCMC or Dong Thap provincial hospital, and resident in the catchment area, were invited to enrol in the cohort and written informed consent was obtained. Women were enrolled either during an antenatal visit in the 9th month of pregnancy or at the time of hospital admission for delivery. Exclusion criteria were girls aged <15 years, those intending to relocate within 12 months and, in HCMC only, women known to be HIV positive. Infants were enrolled within 72 hours of birth, prior to hospital discharge. Enrolment in the cohort began on 1 July 2009 in HCMC and 1 August 2009 in Dong Thap, and is continuing.
Socio-demographic information, obstetric history, infant’s sex, gestational age, delivery method, birth weight and length, breast feeding status, and other post delivery conditions were recorded at baseline. Cord blood (5-20mls) was collected in the labour ward and a maternal blood sample (2mls) was collected within 72 hrs of delivery.
Infants attended scheduled follow-up visits at 2, 4, 6, 9 and 12 months of age, timed to coincide with the delivery of standard Expanded Programme on Immunization (EPI) and private-sector vaccines. In HCMC these vaccines were made available to study participants at the study clinic; in Dong Thap infants received vaccinations independently at commune health posts. In HCMC infants had two additional follow-up visits at 1 and 3 months of age, co-inciding with a routine ‘well-baby’ check-up and EPI vaccinations respectively.
At each visit, information on the infant’s health, weight, height, breastfeeding status, episodes of illness since the last routine visit, and vaccination record was collected in a standardised electronic questionnaire. Infant blood samples (1 ml) were collected by venous blood sampling at 4, 9 and 12 months of age.
Appointments for routine follow-up visits were scheduled in advance, and infants failing to attend a scheduled visit were contacted that day by a study nurse in order to reschedule. If parents were unable to bring infants to the scheduled visit, questionnaires were completed by telephone.
Loss to follow-up
In the case that a family withdrew from the cohort before the infant’s first birthday, the date and reason for withdrawal were recorded in a standard Outcome CRF in the web database. This CRF was also used to record exit from the cohort due to death, including the date and cause of death.
Surveillance of infectious disease episodes
Clinical surveillance in the infant cohort aimed to capture all illness episodes within the following syndromes: dengue, respiratory infections, diarrhoeal infections, and hand, foot and mouth disease. In order to capture these syndromes, families were asked to alert a study nurse by telephone whenever an infant was sick and to attend the study clinic at one of the research sites (HTD, District 8 hospital and Dong Thap hospital). On presentation to a study clinic, the treating physician recorded details of illness onset, symptoms, and the presumptive diagnosis into a standard case report form (CRF). Illness episodes which did not fall under any of the above clinical syndromes were not documented. A study nurse collected research specimens as indicated by symptoms and the presumptive diagnosis, as shown in Figure 2. If specimens were taken for routine clinical reasons, then findings from these investigations were recorded in the CRF. Infants returning for follow-up care for a single illness episode had repeat CRFs completed, but research specimens were only collected at the first presentation. A new illness episode was defined as 7 days or more between symptom onset dates.
When an infant was admitted to hospital with one of the defined clinical syndromes, detailed clinical data was collected each day for the duration of hospital stay in a standard CRF. Research specimens were collected on admission only if not already collected at an outpatient consultation. Infants received standard medical care according to hospital guidelines. The only exception to this was the referral for admission of all infants diagnosed with dengue by rapid diagnostic test, in order to permit daily follow-up.
In the case that families could not bring an infant to a study clinic for medical care, we asked that they inform a study nurse by telephone and a CRF was completed over the phone. If the study nurse learned during routine follow-up that an infant had been hospitalised without the prior knowledge of study staff, a study doctor subsequently attempted to abstract detailed clinical data from the hospital notes in order to complete the CRF.
Routine and clinical samples were stored immediately at 4°C, then transported to the research laboratory once per day, processed and stored at −20°C within 12 hours of collection. A dengue IgM/IgG/NS1 rapid diagnostic test (Dengue Duo; Standard Diagnostics Korea) was performed at the point-of-care for all infants presenting with fever, and later confirmed according to a diagnostic algorithm that includes serotype-specific RT-PCR, NS1 antigen detection by ELISA, and serology on paired plasma specimens by IgM/IgG capture ELISA, as published previously [13, 14]. Molecular and serological diagnostic testing for other viral pathogens, including influenza virus, rotavirus, norovirus, and enterovirus, will be performed on batched samples.
Data collected at baseline and at routine follow-up visits were recorded in a standardised electronic questionnaire, which stored data directly in an encrypted web-based database. Clinical data recorded at illness presentation in a standard CRF were later double entered into the web database.
Access to the web database is restricted by individual user logins, such that study staff have access only to the forms and datasets that they need and are restricted to read-only or write-only access where appropriate. Electronic forms autofill with patient identifiers, date and time to ensure accuracy, and have built-in data validation tools such as skip patterns, value ranges and dropdown lists to minimise missing and incorrect data. Study participants are identified by a numeric study code that is used on all CRFs and research specimens, and are provided with a study card labelled with this code such that they can be identified when presenting at study clinics.
Characteristics of the cohort population
Study participants were enrolled from all administrative wards (n = 16 in HCMC and 33 in DT) within the catchment areas. The spatial distribution of participants’ residences is shown in Figure 1B.
Baseline characteristics of cohort participants
INFANT CHARACTERISTICS (N)
Gestational age at birth2
≥ 37 weeks
Method of delivery2
≥ 2500 grams
Breastfeeding after birth3
Breastfeeding and formula
Admitted to neonatal ward after birth2
Highest education level attained1
No school/some primary school
Completed primary school
Completed secondary school
Stay at home
Professionals and technicians
Service and sales
Agriculture, craft and trades
Number of pregnancies1
Age at this delivery
27 (24 – 32)
25 (21 – 29)
26 (23 – 31)
Age at first childbirth
25 (21 – 28)
23 (20 – 25)
24 (21 – 27)
Exposure to passive cigarette smoke2
Household crowding (people/room)
2.3 (1.7 – 3.0)
3.0 (2.0 – 4.0)
2.5 (1.7 – 3.0)
Main source of drinking water3
Piped (own residence)
Piped (public tap)
Water treated before drinking2*
Main household fuel4
Keep pigs in household1
Keep birds or poultry in household2
To our knowledge, this is the first longitudinal prospective study of infectious diseases in the first year of life in southeast Asia. A major strength of the study is the ability to link baseline sociodemographic and geolocation data on the mothers and their infants with clinical and laboratory data from acute illness episodes during the first year of life, and also with longitudinal serological data, beginning with cord blood collected at birth. This design permits investigations of individual, environmental, virological, and immunological determinants of infection and disease in infants. Specifically, we are able to investigate the duration and nature of passive protection against infectious diseases by maternal antibody acquired at birth, and to characterise the adaptive immune response in infants following primary infection. This has application for understanding force of infection, correlates of protection, and the potential role for maternal vaccination in protecting infants against some infectious diseases.
A primary research question that informed the design of this cohort study is to identify correlates of immunity and pathogenesis in infants and children exposed to dengue virus infections. Pre-existing non-neutralising antibodies are thought to drive the observed increased incidence of severe disease following secondary, heterotypic dengue virus infections, through a mechanism of antibody-dependent enhancement . Indirect evidence suggests that the same mechanism may explain the age-related epidemiology of dengue in infants in endemic countries, where symptomatic dengue cases occur most frequently between the ages of 4 to 10 months, coinciding with the time at which maternally derived neutralising antibodies to DENV become undetectable but non-neutralising viron-binding antibodies remain detectable [6, 7]. However the degree to which in vitro neutralizing antibody activity, or enhancing antibody activity, correlates with dengue immunity or disease is still uncertain [17–19]. This was strikingly apparent in the recently published results of the first efficacy trial of a dengue vaccine candidate, in which there was no clinical efficacy against the predominant DENV-2 serotype, despite satisfactory immunogenicity as defined by serotype-specific neutralising antibody seropositivity and geometric mean titres . Our study will provide the opportunity to assess directly the way in which pre-existing multitypic anti-DENV antibody shapes infection outcome, as well as to characterise longitudinally the adaptive immune response following a primary DENV infection.
Our cohort was not designed as a population-representative sample; for pragmatic reasons, we restricted our catchment areas to one urban and one mixed urban/rural district where we had existing research collaborations, and where the burden of dengue and other infectious diseases is known to be high. This may limit the generalisability of the epidemiological findings, but is unlikely to affect the external validity of the immunological and virological analyses which are the focus of our primary research questions. The inclusion of both urban and semi-rural cohorts is a strength of our study, since the disease burden and relevant exposures might differ substantially between these settings. Enrolment at obstetric hospitals rather than in the community might skew our sample towards women of higher socio-economic status, although in Vietnam the vast majority of births occur in medical facilities so this is unlikely to be a major source of bias.
The two major challenges for our study are minimising loss to follow-up and maximising ascertainment of acute illness episodes. To date our cohort retention has been high, with 84% of infants completing the 12-month follow-up period. We acknowledge that we will not be able to capture every acute illness episode in our surveillance, and therefore that estimates of disease incidence will be underestimates. The problem of under-ascertainment of acute illness episodes does have the potential to introduce bias into any analyses that compare clinical endpoints between subgroups, where those subgroups are likely to differ systematically in their completeness of case ascertainment – for example, between study sites or socioeconomic groups or infants with different baseline health status. This limitation will be considered when interpreting any subgroup-specific estimates of disease incidence.
Enrolment in the infant cohort is ongoing, and from 1 August 2012 enrolment also began in an extension phase of the cohort. This phase will retain approximately 1000 infants in the cohort from their first birthday until six years of age, but with a reduced schedule of routine data and blood collection every six months and no acute illness surveillance or sampling. Our current research interests are focused on common viral infections of childhood in Vietnam, namely dengue, influenza, and hand foot and mouth disease, and viral and bacterial enteric diseases. However the study provides a platform that could easily accommodate additional endpoints in the future, including non-communicable diseases such as asthma, allergy and obesity, which are likely to become increasing health problems in this setting.
Additional members of the Birth Cohort Study team who contributed to the design and implementation of the study are as follows: Nguyen Thanh Tien, Nguyen Thi Hong Van, Bridget Wills, Jeremy Farrar (Oxford University Clinical Research Unit); Nguyen Van Truong (Hung Vuong Hospital); Mai Ngoc Lanh, Pham Thi Hong Phuong, Vo Thi Bich Ngoc, Dang Thi Ngoc Ha, Le Thi Phuong (Dong Thap Hospital); Nguyen Thi Thanh Thuy (District 8 Hospital); Nguyen Thanh Hung, Nguyen Minh Tuan (Children’s Hospital No. 1 HCMC).
The authors gratefully acknowledge the participation of all cohort infants and their families. We also give thanks to all the research nurses, hospital nurses and physicians, laboratory technicians, data entry staff and support staff at the collaborating sites.
This work is support by the Wellcome Trust [Senior Fellowship Award 084368/Z/07/Z to C.P.S]. The funding body had no role in the study design, the collection, analysis and interpretation of data, the writing of the manuscript, or the decision to submit the manuscript for publication.
- Hsieh CJ, Hsieh WS, Su YN, Liao HF, Jeng SF, Taso FM, Hwang YH, Wu KY, Chen CY, Guo YL, Chen PC: The Taiwan birth panel study: a prospective cohort study for environmentally- related child health. BMC Res Notes. 2011, 4: 291-10.1186/1756-0500-4-291.PubMed CentralView ArticlePubMed
- Kishi R, Sasaki S, Yoshioka E, Yuasa M, Sata F, Saijo Y, Kurahashi N, Tamaki J, Endo T, Sengoku K, Nonomura K, Minakami H: Cohort profile: the Hokkaido study on environment and children’s health in Japan. Int J Epidemiol. 2011, 40: 611-618. 10.1093/ije/dyq071.View ArticlePubMed
- Kim BM, Ha M, Park HS, Lee BE, Kim YJ, Hong YC, Kim Y, Chang N, Roh YM, Kim BN, Oh S, Ha EH: The mothers and Children’s environmental health (MOCEH) study. Eur J Epidemiol. 2009, 24: 573-583. 10.1007/s10654-009-9370-7.PubMed CentralView ArticlePubMed
- Turner C, Turner P, Cararra V, Eh Lwe N, Watthanaworawit W, Day NP, White NJ, Goldblatt D, Nosten F: A high burden of respiratory syncytial virus associated pneumonia in children less than two years of age in a south east Asian refugee population. PLoS One. 2012, 7: e50100-10.1371/journal.pone.0050100.PubMed CentralView ArticlePubMed
- Pengsaa K, Luxemburger C, Sabchareon A, Limkittikul K, Yoksan S, Chambonneau L, Chaovarind U, Sirivichayakul C, Lapphra K, Chanthavanich P, Lang J: Dengue virus infections in the first 2 years of life and the kinetics of transplacentally transferred dengue neutralizing antibodies in Thai children. J Infect Dis. 2006, 194: 1570-1576. 10.1086/508492.View ArticlePubMed
- Chau TNB, Hieu NT, Anders KL, Wolbers M, Lien LB, Hieu LTM, Hien TT, Hung NT, Farrar JJ, Whitehead SS, Simmons CP: Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants. J Infect Dis. 2009, 200: 1893-1900. 10.1086/648407.PubMed CentralView ArticlePubMed
- Chau TNB, Quyen NTH, Thuy TT, Tuan NM, Hoang DM, Dung NTP, Lien LB, Quy NT, Hieu NT, Hieu LTM, Hien TT, Hung NT, Farrar JJ, Simmons CP: Dengue in Vietnamese infants–results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. J Infect Dis. 2008, 198: 516-524. 10.1086/590117.PubMed CentralView ArticlePubMed
- Anders KL, Nguyet NM, Chau NVV, Hung NT, Thuy TT, Lien LB, Farrar JJ, Wills B, Hien TT, Simmons CP: Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh city, Vietnam. Am J Trop Med Hyg. 2011, 84: 127-134. 10.4269/ajtmh.2011.10-0476.PubMed CentralView ArticlePubMed
- My PVT, Thompson C, Le PH, Tuyet PTN, Vinh H, Hoang NVM, Van MP, Vinh NT, Thuy CT, Nga TTT, Hau NTT, Campbell J, Chinh NT, Thuong TC, Tuan HM, Farrar J, Baker S: Endemic norovirus infections in children, Ho Chi Minh city, Vietnam, 2009–2010. Emerg Infect Dis. 2013, 19: 977-980. 10.3201/eid1906.111862.PubMed CentralView ArticlePubMed
- Nguyen TA, Yagyu F, Okame M, Phan TG, Trinh QD, Yan H, Hoang KT, Thi A, Cao H, Le HP, Okitsu S, Ushijima H: Diversity of viruses associated with acute gastroenteritis in children hospitalized with diarrhea in Ho Chi Minh city, Vietnam. J Med Virol. 2007, 79: 582-590. 10.1002/jmv.20857.View ArticlePubMed
- Do AHL, van Doorn HR, Nghiem MN, Bryant JE, Hoang THT, Do QH, Le VT, Tran TT, Wills B, Nguyen VC V, Vo MH, Vo CK, Nguyen MD, Farrar J, Tran TH, de Jong MD: Viral etiologies of acute respiratory infections among hospitalized Vietnamese children in Ho Chi Minh city, 2004–2008. PLoS One. 2011, 6: e18176-10.1371/journal.pone.0018176.PubMed CentralView ArticlePubMed
- Khanh TH, Sabanathan S, Thanh TT, Thoa LPK, Thuong TC, Hang V thi T, Farrar J, Hien TT, Chau N van V, van Doorn HR: Enterovirus 71-associated hand, foot, and mouth disease, southern Vietnam, 2011. Emerg Infect Dis. 2012, 18: 2002-2005. 10.3201/eid1812.120929.PubMed CentralView ArticlePubMed
- Hang VT, Nguyet NM, Trung DT, Tricou V, Yoksan S, Dung NM, Van Ngoc T, Hien TT, Farrar JJ, Wills B, Simmons CP: Diagnostic accuracy of NS1 ELISA and lateral flow rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody responses. PLoS Negl Trop Dis. 2009, 3: e360-10.1371/journal.pntd.0000360.View ArticlePubMed
- Hue KDT, Tuan TV, Thi HTN, Bich CTN, Anh HH L, Wills B, Simmons CP: Validation of an internally controlled one-step real-time multiplex RT-PCR assay for the detection and quantitation of dengue virus RNA in plasma. J Virol Methods. 2011, 177: 168-173. 10.1016/j.jviromet.2011.08.002.PubMed CentralView ArticlePubMed
- United Nations population Funds: Recent change in the Sex ratio at birth in Viet Nam. 2009, Ha Noi, Viet Nam: A review of evidence
- Halstead SB: Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis. 2012, 11 (Suppl 4): S830-S839.
- Laoprasopwattana K, Libraty DH, Endy TP, Nisalak A, Chunsuttiwat S, Vaughn DW, Reed G, Ennis FA, Rothman AL, Green S: Dengue virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection. J Infect Dis. 2005, 192: 510-519. 10.1086/431520.View ArticlePubMed
- Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA, Rothman AL, Libraty DH: Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis. 2004, 189: 990-1000. 10.1086/382280.View ArticlePubMed
- Libraty DH, Acosta LP, Tallo V, Segubre-Mercado E, Bautista A, Potts JA, Jarman RG, Yoon I-K, Gibbons RV, Brion JD, Capeding RZ: A prospective nested case–control study of dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model. PLoS Med. 2009, 6: e1000171-10.1371/journal.pmed.1000171.PubMed CentralView ArticlePubMed
- Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, Dulyachai W, Pengsaa K, Wartel TA, Moureau A, Saville M, Bouckenooghe A, Viviani S, Tornieporth NG, Lang J: Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet. 2012, 6736: 1-11.
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/13/937/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.